Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NKAIN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
H2AFV - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GTSE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC644135 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RPAIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANGPT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTUS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBL4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPV3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGEF37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on